Nisa Investment Advisors, LLC Athira Pharma, Inc. Transaction History

Nisa Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $40 - $61	-17 Reduced 42.5%	23 $0
Q1 2023 May 02, 2023	SELL	$2.26 - $4.22 $10,301 - $19,234	-4,558 Reduced 99.13%	40 $0
Q4 2022 Feb 02, 2023	BUY	$2.76 - $3.71 $270 - $363	98 Added 2.18%	4,598 $15,000
Q3 2022 Nov 07, 2022	BUY	$2.93 - $3.96 $12,493 - $16,885	4,264 Added 1806.78%	4,500 $15,000
Q2 2022 Aug 03, 2022	SELL	$2.74 - $13.43 $4,658 - $22,831	-1,700 Reduced 87.81%	236 $1,000
Q1 2022 Apr 29, 2022	BUY	$8.96 - $13.51 $15,232 - $22,967	1,700 Added 720.34%	1,936 $26,000
Q4 2021 Feb 03, 2022	SELL	$9.17 - $16.39 $2,980 - $5,326	-325 Reduced 57.93%	236 $2,000
Q3 2021 Oct 18, 2021	SELL	$9.15 - $11.09 $41,614 - $50,437	-4,548 Reduced 89.02%	561 $5,000
Q4 2020 Jan 25, 2021	BUY	$16.48 - $34.3 $84,196 - $175,238	5,109 New	5,109 $175,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.